Sergio Padilla
Impact in
- Virology top 2%
- HIV Research and Treatment
- Emergency Medicine top 0.5%
- HIV-related health complications and treatments
Papers in
-
- HIV/AIDS drug development and treatment 9
- COVID-19 Clinical Research Studies 7
-
- HIV-related health complications and treatments 26
- Co-authors
- Mar Masiá (87 shared papers)Félix Gutiérrez (90 shared papers)José Manuel Ramos (21 shared papers)Ildefonso Hernández‐Aguado (14 shared papers)Lorena García‐Fernández (7 shared papers)Roberto Rodríguez–Jiménez (6 shared papers)Verónica Romero‐Ferreiro (7 shared papers)Carlos Santos‐Ocaña (9 shared papers)
- Journals
- Clinical Infectious Diseases (7 papers)PLoS ONE (6 papers)Journal of Antimicrobial Chemotherapy (6 papers)Open Forum Infectious Diseases (4 papers)AIDS (4 papers)
- Partner nations
- SpainUnited StatesRussia
In The Last Decade
Sergio Padilla
110 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 135
- Virology 378
- Emergency Medicine 575
- Infectious Diseases 928
- Aging 51
- Biochemistry 157
Countries citing papers authored by Sergio Padilla
This map shows the geographic impact of Sergio Padilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Padilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Padilla more than expected).
Fields of papers citing papers by Sergio Padilla
This network shows the impact of papers produced by Sergio Padilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Padilla. The network helps show where Sergio Padilla may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergio Padilla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 185 | |
| 2 | 2006 | 170 | |
| 3 | 2005 | 142 | |
| 4 | 2020 | 113 | |
| 5 | 2020 | 105 | |
| 6 | 2020 | 104 | |
| 7 | 2021 | 102 | |
| 8 | 2002 | 88 | |
| 9 | 2005 | 77 | |
| 10 | 2003 | 72 | |
| 11 | 2004 | 59 | |
| 12 | 2008 | 58 | |
| 13 | A bibliometric analysis of tuberculosis research indexed in PubMed, 1997-2006. | 2008 | 58 |
| 14 | 2007 | 57 | |
| 15 | 2020 | 55 | |
| 16 | 2011 | 55 | |
| 17 | 2012 | 52 | |
| 18 | 2011 | 52 | |
| 19 | 1998 | 49 | |
| 20 | 2012 | 47 |
About Sergio Padilla
Sergio Padilla is a scholar working on Infectious Diseases, Emergency Medicine, Epidemiology, Virology and Molecular Biology, having authored 114 papers that have together received 3.3k indexed citations. Recurring topics across this work include HIV-related health complications and treatments (26 papers), HIV Research and Treatment (12 papers), Coenzyme Q10 studies and effects (9 papers), HIV/AIDS drug development and treatment (9 papers), Biochemical Acid Research Studies (8 papers), COVID-19 Clinical Research Studies (7 papers), Viral-associated cancers and disorders (6 papers) and Long-Term Effects of COVID-19 (6 papers). The work is most often cited by research in Virology (378 citations), Emergency Medicine (575 citations), Infectious Diseases (928 citations), Aging (51 citations) and Biochemistry (157 citations). Sergio Padilla has collaborated with scholars based in Spain, United States and Russia. Frequent co-authors include Mar Masiá, Félix Gutiérrez, José Manuel Ramos, Ildefonso Hernández‐Aguado, Lorena García‐Fernández, Roberto Rodríguez–Jiménez, Verónica Romero‐Ferreiro, Carlos Santos‐Ocaña, Juan Carlos Rodrı́guez and Marta Fernández‐González. Their work appears in journals such as Clinical Infectious Diseases, PLoS ONE, Journal of Antimicrobial Chemotherapy, Open Forum Infectious Diseases and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.